Format

Send to

Choose Destination
Am J Transplant. 2001 Nov;1(4):307-12.

Cytomegalovirus (CMV) resistance to antivirals.

Author information

1
Department of Laboratory Medicine, UCSF Mt. Zion Medical Center, San Francisco, CA, USA. Lawrence.Drew@clinlab.ucsfmedctr.org

Abstract

This article reviews the biology of cytomegalovirus (CMV), the approved antiviral therapies, and mechanisms of resistance to these drugs. The rates of resistance development in clinical trials are presented, as are the assays for testing susceptibility by phenotypic and genotypic methods. Factors that favor the development of clinical and in vitro antiviral resistance are discussed. Finally, approaches to altering antiviral therapy as resistance develops are outlined.

PMID:
12099372
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center